Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2026 earnings results
Alnylam Pharmaceuticals, Inc. (ALNY) reported Q3 2026 results on Oct 29, 2026, 8:16:25 AM ET: adjusted EPS $16.26 vs. $2.25 expected (beat by 623.0%); revenue $1.46B vs. $1.43B expected (beat by 2.0%). Outlook: The company remains on track to achieve its 2026 financial guidance.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $16.26 | $2.25 | Beat by 623.0% |
| Revenue | $1.46B | $1.43B | Beat by 2.0% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Oct 29, 2026, 8:16:25 AM ET. Nexqual published them 66 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 16.7% from $1.25B.
Stock reaction
The results came out before the market opened. ALNY closed at $174.00 on October 29, 2026, down 25.1% from its $232.40 close on October 28, 2026 before the results.
Questions and answers
Did Alnylam Pharmaceuticals, Inc. beat earnings expectations?
Yes. Alnylam Pharmaceuticals, Inc. reported adjusted EPS of $16.26 against an average analyst estimate of $2.25 (beat by 623.0%), and revenue of $1.46B against $1.43B expected (beat by 2.0%).
What were Alnylam Pharmaceuticals, Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $16.26 and revenue of $1.46B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 16.7% from $1.25B.
When did Alnylam Pharmaceuticals, Inc. report Q3 2026 earnings?
Oct 29, 2026, 8:16:25 AM ET, in an SEC 8-K filing (Item 2.02).
How did ALNY stock react to the earnings?
The results came out before the market opened. ALNY closed at $174.00 on October 29, 2026, down 25.1% from its $232.40 close on October 28, 2026 before the results.
What did Alnylam Pharmaceuticals, Inc. say about its outlook?
The company remains on track to achieve its 2026 financial guidance.
More on ALNY
ALNY stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 29, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built October 29, 2026 at 23:08 UTC. Not investment advice.
Data source: Nexqual. Last updated: October 29, 2026 at 23:08 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt